Back to User profile » Prof. Dr. Maha Aldubayan
Papers published by Prof. Dr. Maha Aldubayan:
Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment
Alshammari AO, Aldubayan MA, Alwashmi AH, Alhowail AH
Drug Design, Development and Therapy 2026, 20:561133
Published Date: 3 June 2026
Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress
Alharbi MS, Aldubayan MA
Drug Design, Development and Therapy 2025, 19:11483-11497
Published Date: 23 December 2025
Comparative Analysis of Pioglitazone and Tirzepatide on Body Weight, Glucose Levels, Neuroinflammation, and Oxidative Stress in Diabetic Rats
Alhowail A, Aldawsari MF, Aldubayan M
Drug Design, Development and Therapy 2025, 19:6605-6618
Published Date: 31 July 2025
Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature
Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI
Drug Design, Development and Therapy 2022, 16:2919-2931
Published Date: 31 August 2022
Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7
Abdellatif AAH, Rasheed Z, Alhowail AH, Alqasoumi A, Alsharidah M, Khan RA, Aljohani ASM, Aldubayan MA, Faisal W
International Journal of Nanomedicine 2020, 15:8479-8493
Published Date: 30 October 2020